ECM1 and cancer: Extracellular matrix protein-1 (ECM1) induces cisplatin resistance via integrin αXβ2 and downstream activation of Akt/FAK/Rho signaling, leading to ABC sub-family G member 1 (ABCG1)-mediated enhancement of cancer stem-like traits [72].